University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Bigmingham, UK.
Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
J Int Adv Otol. 2020 Dec;16(3):411-431. doi: 10.5152/iao.2020.9035.
To establish outcomes following cochlear implantation (CI) in patients with postsynaptic auditory neuropathy (AN). Systematic review and narrative synthesis. Databases searched: MEDLINE, PubMed, EMBASE, Web of Science, Cochrane Collection and ClinicalTrials.gov. No limits placed on language or year of publication. Review conducted in accordance with the PRISMA statement. Searches identified 98 studies in total, of which 14 met the inclusion criteria reporting outcomes in 25 patients with at least 28 CIs. Of these, 4 studies focused on Charcot-Marie-Tooth disease (CMT), 3 on Brown-Vialetto-Van-Laere syndrome (BVVL), 2 on Friedreich Ataxia (FRDA), 2 on Syndromic dominant optic atrophy (DOA+), 2 on Cerebellar ataxia - areflexia - pes cavus - optic atrophy - sensorineural hearing loss (CAPOS) syndrome, and 1 on Deafness-dystonia-optic neuronopathy (DDON) syndrome. All studies were Oxford Centre for Evidence Based Medicine (OCEBM) grade IV. Overall trend was towards good post-CI outcomes with 22 of the total 25 patients displaying modest to significant benefit. Hearing outcomes following CI in postsynaptic ANs are variable but generally good with patients showing improvements in hearing thresholds and speech perception. In the future, development of a clearer stratification system into pre, post, and central AN would have clinical and academic benefits. Further research is required to understand AN pathophysiology and develop better diagnostic tools for more accurate identification of lesion sites. Multicenter longitudinal studies with standardized comprehensive outcome measures including health-related quality of life data will be key in establishing a better understanding of short and long-term post-CI outcomes.
探讨突触后性听觉神经病(AN)患者人工耳蜗植入(CI)后的结局。方法:系统评价和叙述性综合。检索数据库:MEDLINE、PubMed、EMBASE、Web of Science、Cochrane 图书馆和 ClinicalTrials.gov。不限制语言或发表年份。根据 PRISMA 声明进行综述。共检索到 98 项研究,其中 14 项符合纳入标准,共纳入 25 例至少接受 28 次 CI 的患者,报告了其结局。其中,4 项研究集中于遗传性运动感觉神经病(CMT),3 项研究集中于 Brown-Vialetto-Van-Laere 综合征(BVVL),2 项研究集中于 Friedreich 共济失调(FRDA),2 项研究集中于综合征性显性视神经萎缩(DOA+),2 项研究集中于小脑共济失调-反射消失-高弓足-视神经萎缩-感觉神经性耳聋(CAPOS)综合征,1 项研究集中于耳聋-肌强直-视神经病变(DDON)综合征。所有研究均为牛津循证医学中心(OCEBM)证据分级 IV 级。总体趋势是 CI 后有 22 例患者(22/25)出现适度至显著获益。突触后性 AN 患者 CI 后的听力结局存在差异,但总体良好,患者的听力阈值和言语感知均有改善。未来,制定更清晰的前、后和中枢 AN 分类系统将具有临床和学术意义。需要进一步研究以了解 AN 的病理生理学,并开发更好的诊断工具,以更准确地识别病变部位。采用标准化的全面结局评估,包括健康相关生活质量数据的多中心纵向研究,将是确定短期和长期 CI 后结局的关键。